Abstract
Intravenous thrombolysis with rt-PA within three hours of symptom onset is the only proven effective treatment for acute ischemic stroke. The European license limits the use of rt-PA to patients aged < 80 years for the lack of clear evidence of safety and efficacy of this treatment in the elderly.
Keywords: Ischemic stroke, Intravenous thrombolysis, rt-PA, Elderly
Letters in Drug Design & Discovery
Title: Intravenous Thrombolysis with rt-PA in Acute Stroke Patients Aged ≥80 Years
Volume: 5 Issue: 3
Author(s): S. Lorenzano, F. Orzi, E. Puca and D. Toni
Affiliation:
Keywords: Ischemic stroke, Intravenous thrombolysis, rt-PA, Elderly
Abstract: Intravenous thrombolysis with rt-PA within three hours of symptom onset is the only proven effective treatment for acute ischemic stroke. The European license limits the use of rt-PA to patients aged < 80 years for the lack of clear evidence of safety and efficacy of this treatment in the elderly.
Export Options
About this article
Cite this article as:
Lorenzano S., Orzi F., Puca E. and Toni D., Intravenous Thrombolysis with rt-PA in Acute Stroke Patients Aged ≥80 Years, Letters in Drug Design & Discovery 2008; 5 (3) . https://dx.doi.org/10.2174/157018008784084009
DOI https://dx.doi.org/10.2174/157018008784084009 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effect of Cardiovascular Injury on Catabolism of Adenosine and Adenosine 5-‘Triphosphate in Systemic Blood in a Freely Moving Rat Model In Vivo
Drug Metabolism Letters Progression of Renal Dysfunction in Patients with Cardiovascular Disease
Current Cardiology Reviews The Gut and Intestinal Bacteria in Chronic Heart Failure
Current Drug Metabolism Repetitive Transcranial Magnetic Stimulation to Treat Substance Use Disorders and Compulsive Behavior
CNS & Neurological Disorders - Drug Targets Treatment for Obsessive Compulsive Disorder
Current Psychiatry Reviews Effects of PPARγ Ligands on Vascular Tone
Current Molecular Pharmacology Cardioprotective Effect of Resveratrol and Resveratroloside
Cardiovascular & Hematological Agents in Medicinal Chemistry The Role of Heat Shock Protein 90 and Endothelial Nitric Oxide Synthase Signaling in Cardiovascular Therapy
Current Signal Transduction Therapy Empagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Current Diabetes Reviews Ginger and Heart Health: From Mechanisms to Therapeutics
Current Molecular Pharmacology Editorial (Forward Look: Tenth Anniversary of the Human Genome Sequence and 21st Century Postgenomics Global Health - A Close Up on Africa and Womens Health)
Current Pharmacogenomics and Personalized Medicine Liver X Receptors
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Beyond Cholesterol Lowering: Pleiotropic Effects of Bile Acid Binding Resins Against Cardiovascular Disease Risk Factors in Patients with Metabolic Syndrome
Current Vascular Pharmacology CD31+ Circulating Angiogenic Cell Number and Subtypes are Reduced in Individuals with Chronic Stroke
Current Neurovascular Research Clinical Presentations and Diagnosis of Brucellosis
Recent Patents on Anti-Infective Drug Discovery Valsartan Protects Against Contrast-Induced Acute Kidney Injury in Rats by Inhibiting Endoplasmic Reticulum Stress-Induced Apoptosis
Current Vascular Pharmacology Editorial [Hot Topic: Inflammation as Target for Pharmaceutical Intervention in Cancer (Executive Editors: R.M. Schiffelers and K.E. de Visser)]
Current Pharmaceutical Design Deprescribing Antipsychotic Medications in Psychotic Disorders: How and Why?
Current Psychiatry Reviews Effects of Tea Catechins on Inflammation-Related Cardiovascular Diseases
Current Immunology Reviews (Discontinued) Vascular Risk Factors, Vascular Diseases, and Imaging Findings in a Hospital-based Cohort of Mild Cognitive Impairment Types
Current Alzheimer Research